nodes	percent_of_prediction	percent_of_DWPC	metapath
Stanozolol—Danazol—Hydrocortisone—systemic lupus erythematosus	0.0873	0.0879	CrCrCtD
Stanozolol—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.0759	0.0765	CrCrCtD
Stanozolol—Danazol—Prednisone—systemic lupus erythematosus	0.0752	0.0757	CrCrCtD
Stanozolol—Fluoxymesterone—Hydrocortisone—systemic lupus erythematosus	0.0656	0.0661	CrCrCtD
Stanozolol—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.0639	0.0644	CrCrCtD
Stanozolol—Progesterone—Hydrocortisone—systemic lupus erythematosus	0.0639	0.0644	CrCrCtD
Stanozolol—Methyltestosterone—Hydrocortisone—systemic lupus erythematosus	0.0623	0.0628	CrCrCtD
Stanozolol—Fluoxymesterone—Dexamethasone—systemic lupus erythematosus	0.0609	0.0614	CrCrCtD
Stanozolol—Fluoxymesterone—Betamethasone—systemic lupus erythematosus	0.0609	0.0614	CrCrCtD
Stanozolol—Fluoxymesterone—Triamcinolone—systemic lupus erythematosus	0.0595	0.06	CrCrCtD
Stanozolol—Testosterone—Hydrocortisone—systemic lupus erythematosus	0.0555	0.0559	CrCrCtD
Stanozolol—Fluoxymesterone—Prednisolone—systemic lupus erythematosus	0.0551	0.0556	CrCrCtD
Stanozolol—Progesterone—Prednisolone—systemic lupus erythematosus	0.0537	0.0541	CrCrCtD
Stanozolol—Methyltestosterone—Prednisone—systemic lupus erythematosus	0.0537	0.0541	CrCrCtD
Stanozolol—Methyltestosterone—Prednisolone—systemic lupus erythematosus	0.0524	0.0528	CrCrCtD
Stanozolol—Testosterone—Prednisolone—systemic lupus erythematosus	0.0466	0.047	CrCrCtD
Stanozolol—Danazol—CCL2—systemic lupus erythematosus	0.00191	0.523	CrCbGaD
Stanozolol—Fluoxymesterone—NR3C1—systemic lupus erythematosus	0.000677	0.185	CrCbGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—HIP1—systemic lupus erythematosus	0.000555	0.146	CbGpPWpGaD
Stanozolol—Progesterone—NR3C1—systemic lupus erythematosus	0.000335	0.0918	CrCbGaD
Stanozolol—Norethindrone—ALB—systemic lupus erythematosus	0.000291	0.0797	CrCbGaD
Stanozolol—Methyltestosterone—ALB—systemic lupus erythematosus	0.000276	0.0757	CrCbGaD
Stanozolol—AR—Coregulation of Androgen receptor activity—XRCC6—systemic lupus erythematosus	0.000217	0.0568	CbGpPWpGaD
Stanozolol—Testosterone—ALB—systemic lupus erythematosus	0.00016	0.0439	CrCbGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—RASGRP3—systemic lupus erythematosus	0.000154	0.0405	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—RXRA—systemic lupus erythematosus	0.000143	0.0375	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—VDR—systemic lupus erythematosus	0.000129	0.034	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—NR3C1—systemic lupus erythematosus	0.000116	0.0306	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—RXRA—systemic lupus erythematosus	0.000113	0.0296	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—RXRA—systemic lupus erythematosus	0.000109	0.0287	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.000109	0.0285	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.000109	0.0285	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—VDR—systemic lupus erythematosus	0.000102	0.0268	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—NR3C1—systemic lupus erythematosus	9.2e-05	0.0242	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptors—PPARG—systemic lupus erythematosus	9.02e-05	0.0237	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—NR3C1—systemic lupus erythematosus	8.93e-05	0.0234	CbGpPWpGaD
Stanozolol—AR—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	7.13e-05	0.0187	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—VDR—systemic lupus erythematosus	7.06e-05	0.0185	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—IL10—systemic lupus erythematosus	6.87e-05	0.018	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—NR3C1—systemic lupus erythematosus	6.36e-05	0.0167	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—CD4—systemic lupus erythematosus	6.03e-05	0.0158	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—CDKN1B—systemic lupus erythematosus	5.98e-05	0.0157	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—GADD45A—systemic lupus erythematosus	5.73e-05	0.015	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	5.68e-05	0.0149	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—CDKN1B—systemic lupus erythematosus	5.67e-05	0.0149	CbGpPWpGaD
Stanozolol—AR—FOXA1 transcription factor network—EP300—systemic lupus erythematosus	5.25e-05	0.0138	CbGpPWpGaD
Stanozolol—AR—Notch-mediated HES/HEY network—EP300—systemic lupus erythematosus	4.98e-05	0.0131	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	4.75e-05	0.0125	CbGpPWpGaD
Stanozolol—AR—Regulation of Androgen receptor activity—EP300—systemic lupus erythematosus	4.52e-05	0.0119	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	4.48e-05	0.0118	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	4.07e-05	0.0107	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—JAK1—systemic lupus erythematosus	3.98e-05	0.0105	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.93e-05	0.0103	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	3.76e-05	0.00988	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—systemic lupus erythematosus	3.43e-05	0.00901	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—systemic lupus erythematosus	3.39e-05	0.00889	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—systemic lupus erythematosus	3.25e-05	0.00854	CbGpPWpGaD
Stanozolol—AR—Gene Expression—SNRPD1—systemic lupus erythematosus	3.22e-05	0.00846	CbGpPWpGaD
Stanozolol—AR—Regulation of nuclear SMAD2/3 signaling—EP300—systemic lupus erythematosus	3.22e-05	0.00845	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.22e-05	0.00844	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—CDKN1A—systemic lupus erythematosus	3.14e-05	0.00824	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.1e-05	0.00814	CbGpPWpGaD
Stanozolol—AR—Androgen receptor signaling pathway—EP300—systemic lupus erythematosus	2.99e-05	0.00784	CbGpPWpGaD
Stanozolol—AR—Gene Expression—MTA2—systemic lupus erythematosus	2.92e-05	0.00765	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	2.23e-05	0.00584	CbGpPWpGaD
Stanozolol—AR—Gene Expression—TNFSF13—systemic lupus erythematosus	1.97e-05	0.00517	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—EP300—systemic lupus erythematosus	1.96e-05	0.00514	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	1.95e-05	0.00512	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.95e-05	0.00512	CbGpPWpGaD
Stanozolol—AR—Gene Expression—SNRPB—systemic lupus erythematosus	1.91e-05	0.00501	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	1.91e-05	0.005	CbGpPWpGaD
Stanozolol—AR—Integrated Breast Cancer Pathway—VEGFA—systemic lupus erythematosus	1.85e-05	0.00487	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.85e-05	0.00485	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	1.81e-05	0.00474	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—VDR—systemic lupus erythematosus	1.77e-05	0.00464	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.7e-05	0.00447	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.62e-05	0.00426	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	1.59e-05	0.00417	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.55e-05	0.00406	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.54e-05	0.00403	CbGpPWpGaD
Stanozolol—AR—Gene Expression—HIST2H2AC—systemic lupus erythematosus	1.53e-05	0.00402	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.41e-05	0.0037	CbGpPWpGaD
Stanozolol—AR—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.32e-05	0.00345	CbGpPWpGaD
Stanozolol—AR—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	1.25e-05	0.00328	CbGpPWpGaD
Stanozolol—AR—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	1.23e-05	0.00323	CbGpPWpGaD
Stanozolol—AR—Gene Expression—JUNB—systemic lupus erythematosus	1.07e-05	0.00281	CbGpPWpGaD
Stanozolol—AR—Gene Expression—RXRA—systemic lupus erythematosus	9.39e-06	0.00246	CbGpPWpGaD
Stanozolol—AR—Gene Expression—VDR—systemic lupus erythematosus	8.5e-06	0.00223	CbGpPWpGaD
Stanozolol—AR—Gene Expression—NR3C1—systemic lupus erythematosus	7.65e-06	0.00201	CbGpPWpGaD
Stanozolol—AR—Gene Expression—PPARG—systemic lupus erythematosus	5.93e-06	0.00156	CbGpPWpGaD
